Quéval P and Beaumatin J |
[Study of the inductor effect of 5,6-benzoflavone on the activity of pulmonary benzopyrene monoxidase. Comparison with other chemical or physical agents]. |
1979 |
C. R. Acad. Sci., D, Sci. Nat. |
pmid:111845
|
Cavé A et al. |
[Pachypodol (5,4'-dihydroxy 3,7,3'-trimethoxy flavone or 3,7,3'-quercetol trimethylether), a new flavonoid isolated from Pachypodanthium confine Engler and Diels (annonaceae)]. |
1973 |
C.R. Hebd. Seances Acad. Sci., Ser. D, Sci. Nat. |
pmid:4201538
|
McKeage MJ and Baguley BC |
Disrupting established tumor blood vessels: an emerging therapeutic strategy for cancer. |
2010 |
Cancer |
pmid:20166210
|
Li YR et al. |
Tangeretin derivative, 5-acetyloxy-6,7,8,4'-tetramethoxyflavone induces G2/M arrest, apoptosis and autophagy in human non-small cell lung cancer cells in vitro and in vivo. |
2016 |
Cancer Biol. Ther. |
pmid:26569090
|
Lagiou P et al. |
Flavonoid intake and liver cancer: a case-control study in Greece. |
2008 |
Cancer Causes Control |
pmid:18350370
|
Hirvonen T et al. |
Flavonol and flavone intake and the risk of cancer in male smokers (Finland). |
2001 |
Cancer Causes Control |
pmid:11714106
|
Büchner FL et al. |
Fruits and vegetables consumption and the risk of histological subtypes of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). |
2010 |
Cancer Causes Control |
pmid:19924549
|
Weiss GR et al. |
New anticancer agents. |
1988 |
Cancer Chemother Biol Response Modif |
pmid:2484323
|
Weiss GR et al. |
New anticancer agents. |
1987 |
Cancer Chemother Biol Response Modif |
pmid:2484330
|
Cai H et al. |
Tissue distribution in mice and metabolism in murine and human liver of apigenin and tricin, flavones with putative cancer chemopreventive properties. |
2007 |
Cancer Chemother. Pharmacol. |
pmid:17089164
|
Chabot GG et al. |
Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975; NSC-347512) in mice. |
1989 |
Cancer Chemother. Pharmacol. |
pmid:2597279
|
Thomas JP et al. |
Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol. |
2002 |
Cancer Chemother. Pharmacol. |
pmid:12451473
|
Cassidy J et al. |
Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients? |
1989 |
Cancer Chemother. Pharmacol. |
pmid:2713962
|
Chabot GG et al. |
Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitro. |
1989 |
Cancer Chemother. Pharmacol. |
pmid:2758556
|
Cai H et al. |
Pharmacokinetics in mice and metabolism in murine and human liver fractions of the putative cancer chemopreventive agents 3',4',5',5,7-pentamethoxyflavone and tricin (4',5,7-trihydroxy-3',5'-dimethoxyflavone). |
2011 |
Cancer Chemother. Pharmacol. |
pmid:20364427
|
Verschoyle RD et al. |
Preliminary safety evaluation of the putative cancer chemopreventive agent tricin, a naturally occurring flavone. |
2006 |
Cancer Chemother. Pharmacol. |
pmid:16001171
|
Enomoto R et al. |
Wogonin potentiates the antitumor action of etoposide and ameliorates its adverse effects. |
2011 |
Cancer Chemother. Pharmacol. |
pmid:20658136
|
Damia G et al. |
Dose-dependent pharmacokinetics of flavone acetic acid in mice. |
1988 |
Cancer Chemother. Pharmacol. |
pmid:3396145
|
Gouyette A et al. |
Flavone acetic acid: a nonlinear pharmacokinetic model. |
1988 |
Cancer Chemother. Pharmacol. |
pmid:3409441
|
O'Dwyer PJ et al. |
Flavone acetic acid (LM 975, NSC 347512). A novel antitumor agent. |
1987 |
Cancer Chemother. Pharmacol. |
pmid:3545524
|